Dynavax

-$0.38 (-3.40%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Dynavax and other ETFs, options, and stocks.

About DVAX

Dynavax Technologies Corp. operates as a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel vaccines and immuno-oncology therapeutics. Its product includes HEPLISAV-B, which prevents infection caused by all known subtypes of hepatitis B virus in adults 18 years of age and older.

CEO
Ryan Spencer
Employees
311
Headquarters
Emeryville, California
Founded
1996

DVAX Key Statistics

Market cap
1.36B
Price-Earnings ratio
14.62
Dividend yield
—
Average volume
7.54M
High today
$11.31
Low today
$10.24
Open price
$11.15
Volume
3.52M
52 Week high
$21.39
52 Week low
$7.26

DVAX Earnings

-$0.24
$0.07
$0.38
$0.69
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Estimated
— per share
Actual
Expected Aug 4, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure